

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/08/02/2717459/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Announces-Second-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/07/27/2712134/0/en/Quoin-Pharmaceuticals-Announces-Second-Quarter-2023-Financial-Results-and-Corporate-Update-Conference-Call-to-be-held-on-Thursday-August-3rd-at-8-30-am-ET.html
https://www.globenewswire.com/news-release/2023/05/24/2675214/0/en/Quoin-Pharmaceuticals-Announces-50-Enrollment-in-Open-Label-Netherton-Syndrome-Clinical-Trial.html
https://www.globenewswire.com/news-release/2023/05/08/2663918/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Announces-First-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/05/02/2659173/0/en/Quoin-Pharmaceuticals-Announces-First-Quarter-2023-Financial-Results-and-Corporate-Update-Conference-Call-to-Be-Held-on-Tuesday-May-9-2023-at-8-30-am-ET.html
https://www.globenewswire.com/news-release/2023/03/21/2631293/0/en/Quoin-Pharmaceuticals-Doses-First-Patient-in-Open-Label-Netherton-Syndrome-Clinical-Trial.html
https://www.globenewswire.com/news-release/2023/03/02/2619825/0/en/Quoin-Pharmaceuticals-Announces-2022-Corporate-Update-Conference-Call-to-be-held-on-Thursday-March-9th-at-8-30am-ET.html
https://www.globenewswire.com/news-release/2023/02/22/2613258/0/en/Quoin-Pharmaceuticals-Announces-Pricing-of-7-0-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2022/12/13/2572763/0/en/Quoin-Pharmaceuticals-Announces-Dosing-of-First-Patient-in-Clinical-Trial-in-Netherton-Syndrome.html
https://www.globenewswire.com/news-release/2022/11/03/2547395/0/en/Quoin-Pharmaceuticals-Announces-Updated-Timing-of-Third-Quarter-2022-Corporate-Update-Conference-Call-to-be-held-on-Thursday-November-10th.html